These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

485 related articles for article (PubMed ID: 19133796)

  • 1. Neuraminidase inhibitor resistance after oseltamivir treatment of acute influenza A and B in children.
    Stephenson I; Democratis J; Lackenby A; McNally T; Smith J; Pareek M; Ellis J; Bermingham A; Nicholson K; Zambon M
    Clin Infect Dis; 2009 Feb; 48(4):389-96. PubMed ID: 19133796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigenic and genetic characterization of influenza viruses isolated in Mozambique during the 2015 season.
    Tivane A; Daniels R; Nguenha N; Machalele L; Nacoto A; Pale M; Mateonane E; Mavale S; Chilundo J; Muteto D; Salência J; Albati F; Gudo E; Mussá T; McCauley J
    PLoS One; 2018; 13(7):e0201248. PubMed ID: 30048502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuraminidase inhibitor susceptibility profile of pandemic and seasonal influenza viruses during the 2009-2010 and 2010-2011 influenza seasons in Japan.
    Dapat C; Kondo H; Dapat IC; Baranovich T; Suzuki Y; Shobugawa Y; Saito K; Saito R; Suzuki H
    Antiviral Res; 2013 Sep; 99(3):261-9. PubMed ID: 23791870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virological self-sampling to monitor influenza antiviral susceptibility in a community cohort.
    Lackenby A; Elliot AJ; Powers C; Andrews N; Ellis J; Bermingham A; Thompson C; Galiano M; Large S; Durnall H; Fleming D; Smith G; Zambon M
    J Antimicrob Chemother; 2013 Oct; 68(10):2324-31. PubMed ID: 23759670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low antiviral resistance in Influenza A and B viruses isolated in Mexico from 2010 to 2023.
    Franco-May DA; Gómez-Carballo J; Barrera-Badillo G; Cruz-Ortíz MN; Núñez-García TE; Arellano-Suárez DS; Wong-Arámbula C; López-Martínez I; Wong-Chew RM; Ayora-Talavera G
    Antiviral Res; 2024 Jul; 227():105918. PubMed ID: 38795911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008.
    Sheu TG; Deyde VM; Okomo-Adhiambo M; Garten RJ; Xu X; Bright RA; Butler EN; Wallis TR; Klimov AI; Gubareva LV
    Antimicrob Agents Chemother; 2008 Sep; 52(9):3284-92. PubMed ID: 18625765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oseltamivir-resistant influenza viruses isolated in South Korea from 2005 to 2010.
    Cho HG; Choi JH; Lee HK; Mun SK; Lee JB; Jho EH; Kang C; Lim YH
    Arch Virol; 2013 Nov; 158(11):2365-70. PubMed ID: 23690054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oseltamivir-resistant influenza A and B viruses pre- and postantiviral therapy in children and young adults with cancer.
    Carr S; Ilyushina NA; Franks J; Adderson EE; Caniza M; Govorkova EA; Webster RG
    Pediatr Infect Dis J; 2011 Apr; 30(4):284-8. PubMed ID: 21048522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamics of antiviral-resistant influenza viruses in the Netherlands, 2005-2008.
    Jonges M; van der Lubben IM; Dijkstra F; Verhoef L; Koopmans M; Meijer A
    Antiviral Res; 2009 Sep; 83(3):290-7. PubMed ID: 19591877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of oseltamivir treatment started within 5 days of symptom onset to reduce influenza illness duration and virus shedding in an urban setting in Bangladesh: a randomised placebo-controlled trial.
    Fry AM; Goswami D; Nahar K; Sharmin AT; Rahman M; Gubareva L; Azim T; Bresee J; Luby SP; Brooks WA
    Lancet Infect Dis; 2014 Feb; 14(2):109-18. PubMed ID: 24268590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virus load kinetics and resistance development during oseltamivir treatment in infants and children infected with Influenza A(H1N1) 2009 and Influenza B viruses.
    Rath B; von Kleist M; Tief F; Karsch K; Tuerk E; Muehlhans S; Louis F; Skopnik H; Schweiger B; Duwe S
    Pediatr Infect Dis J; 2012 Sep; 31(9):899-905. PubMed ID: 22581220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implications of antiviral resistance of influenza viruses.
    Monto AS
    Clin Infect Dis; 2009 Feb; 48(4):397-9. PubMed ID: 19586376
    [No Abstract]   [Full Text] [Related]  

  • 13. Neuraminidase inhibitor susceptibility surveillance of influenza viruses circulating worldwide during the 2011 Southern Hemisphere season.
    Okomo-Adhiambo M; Sleeman K; Lysén C; Nguyen HT; Xu X; Li Y; Klimov AI; Gubareva LV
    Influenza Other Respir Viruses; 2013 Sep; 7(5):645-58. PubMed ID: 23575174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of aloin on viral neuraminidase and hemagglutinin-specific T cell immunity in acute influenza.
    Huang CT; Hung CY; Hseih YC; Chang CS; Velu AB; He YC; Huang YL; Chen TA; Chen TC; Lin CY; Lin YC; Shih SR; Dutta A
    Phytomedicine; 2019 Nov; 64():152904. PubMed ID: 31454654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiviral susceptibility profile of influenza A viruses; keep an eye on immunocompromised patients under prolonged treatment.
    Kossyvakis A; Mentis AA; Tryfinopoulou K; Pogka V; Kalliaropoulos A; Antalis E; Lytras T; Meijer A; Tsiodras S; Karakitsos P; Mentis AF
    Eur J Clin Microbiol Infect Dis; 2017 Feb; 36(2):361-371. PubMed ID: 27848039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility of influenza A(H1N1)/pdm2009, seasonal A(H3N2) and B viruses to Oseltamivir in Guangdong, China between 2009 and 2014.
    Liu SS; Jiao XY; Wang S; Su WZ; Jiang LZ; Zhang X; Ke CW; Xiong P
    Sci Rep; 2017 Aug; 7(1):8488. PubMed ID: 28814737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virological surveillance and antiviral resistance of human influenza virus in Argentina, 2005-2008.
    Pontoriero A; Baumeister E; Campos AM; Savy VL
    Rev Panam Salud Publica; 2011 Dec; 30(6):634-40. PubMed ID: 22358415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different drug-resistant influenza A(H3N2) variants in two immunocompromised patients treated with oseltamivir during the 2011-2012 influenza season in Italy.
    Piralla A; Gozalo-Margüello M; Fiorina L; Rovida F; Muzzi A; Colombo AA; Alessandrino PE; Baldanti F
    J Clin Virol; 2013 Sep; 58(1):132-7. PubMed ID: 23810646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiviral resistance due to deletion in the neuraminidase gene and defective interfering-like viral polymerase basic 2 RNA of influenza A virus subtype H3N2.
    Trebbien R; Christiansen CB; Fischer TK
    J Clin Virol; 2018 May; 102():1-6. PubMed ID: 29448067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic characterization of circulating seasonal Influenza A viruses (2005-2009) revealed introduction of oseltamivir resistant H1N1 strains during 2009 in eastern India.
    Agrawal AS; Sarkar M; Ghosh S; Roy T; Chakrabarti S; Lal R; Mishra AC; Chadha MS; Chawla-Sarkar M
    Infect Genet Evol; 2010 Dec; 10(8):1188-98. PubMed ID: 20678590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.